Combined PET/MRI: a new dimension in whole-body oncology imaging?

IntroductionHybrid imaging systems providing morphological and functional data in a single session have been available for oncological imaging for some time. So far, computed tomography (CT) has been the morphological method-of-choice for inclusion into these hybrid imaging systems. However, recently, research has focused on hardware-based fusion of function with magnetic resonance imaging (MRI) rather than CT.ObjectivesNow that the first head-only positron emission tomography (PET)/MRI systems have been installed and whole-body systems are to be expected in the near future, potential indications in clinical oncology have to be addressed.DiscussionThis article discusses potential indications of PET/MRI in whole-body oncology imaging. Potential advantages and disadvantages compared with currently available hybrid imaging systems will be reviewed.

[1]  N. Müller,et al.  Mediastinal nodes in bronchogenic carcinoma: comparison between CT and mediastinoscopy. , 1988, Radiology.

[2]  T. Turkington,et al.  Accuracy of Surface Fit Registration for PET and MR Brain Images Using Full and Incomplete Brain Surfaces , 1995, Journal of computer assisted tomography.

[3]  S. Eustace,et al.  Whole-body MR imaging. Practical issues, clinical applications, and future directions. , 1999, Magnetic resonance imaging clinics of North America.

[4]  J. Deslauriers,et al.  Clinical and surgical staging of non-small cell lung cancer. , 2000, Chest.

[5]  S. Schoenberg,et al.  Imaging of lung cancer with CT, MRT and PET. , 2001, Lung cancer.

[6]  J. Debatin,et al.  Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. , 2003, JAMA.

[7]  A. Kuten,et al.  Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  Thomas Beyer,et al.  Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  T. Beyer,et al.  Whole-body fluorine-18 fluordeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in staging of advanced uveal melanoma. , 2004, Survey of ophthalmology.

[10]  G. Antoch,et al.  Value of 124I-PET/CT in staging of patients with differentiated thyroid cancer , 2004, European Radiology.

[11]  G. Antoch,et al.  Value of (124)I-PET/CT in staging of patients with differentiated thyroid cancer. , 2004, European radiology.

[12]  S. Schoenberg,et al.  [Comparison of high resolution whole-body MRI using parallel imaging and PET-CT. First experiences with a 32-channel MRI system]. , 2004, Der Radiologe.

[13]  G. P. Schmidt,et al.  Hochauflösendes Ganzkörpertumorstaging unter Verwendung paralleler Bildgebung im Vergleich zur PET-CT , 2004, Der Radiologe.

[14]  J. Debatin,et al.  Assessment of liver tissue after radiofrequency ablation: findings with different imaging procedures. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  S. Schoenberg,et al.  Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT , 2007, European Radiology.

[16]  T. Beyer,et al.  Diagnostic accuracy of colorectal cancer staging with whole-body PET/CT colonography. , 2006, JAMA.

[17]  P. Parizel,et al.  Magnetic resonance imaging in breast cancer. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[18]  M. Harisinghani,et al.  Lymphotropic nanoparticle enhanced MR imaging (LNMRI) technique for lymph node imaging. , 2006, European journal of radiology.

[19]  Oliver Kraff,et al.  To TOF or not to TOF: strategies for non-contrast-enhanced intracranial MRA at 7 T , 2008, Magnetic Resonance Materials in Physics, Biology and Medicine.

[20]  F. M. Mottaghy,et al.  Integrierte 18F-FDG PET/CT verbessert das nicht invasive T-Staging beim nicht kleinzelligen Bronchialkarzinom , 2007 .

[21]  C. Claussen,et al.  Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma. , 2007, European journal of cancer.

[22]  C. Collins,et al.  PET/CT in oncology: for which tumours is it the reference standard? , 2007, Cancer imaging : the official publication of the International Cancer Imaging Society.

[23]  Rudolf Fahlbusch,et al.  A review of cranial imaging techniques: potential and limitations. , 2007, Clinical neurosurgery.

[24]  J. Fütterer,et al.  Use of ultrasmall superparamagnetic iron oxide in lymph node MR imaging in prostate cancer patients. , 2007, European journal of radiology.

[25]  Carl K Hoh,et al.  Clinical use of FDG PET. , 2007, Nuclear medicine and biology.

[26]  E. Squillaci,et al.  Staging of colon cancer: whole-body MRI vs. whole-body PET-CT—initial clinical experience , 2008, Abdominal Imaging.

[27]  A. Stadler,et al.  Magnetic Resonance Imaging of Liver Malignancies , 2007, Topics in magnetic resonance imaging : TMRI.

[28]  F. Mottaghy,et al.  Improved non-invasive T-Staging in non-small cell lung cancer by integrated18F-FDG PET/CT , 2007, Nuklearmedizin.

[29]  W. Jee,et al.  Various image findings of skeletal muscle metastases with clinical correlation , 2008, Skeletal Radiology.

[30]  Bernd J. Pichler,et al.  PET/MRI hybrid imaging: devices and initial results , 2008, European Radiology.

[31]  E. Hauth,et al.  Whole-body PET/CT-mammography for staging breast cancer: initial results. , 2008, The British journal of radiology.

[32]  Armin Kolb,et al.  Positron emission tomography/magnetic resonance imaging: the next generation of multimodality imaging? , 2008, Seminars in nuclear medicine.

[33]  S. Schoenberg,et al.  Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT. , 2008, European journal of radiology.

[34]  R. Hawkins,et al.  Diagnostic value of PET/CT for the staging and restaging of pediatric tumors , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[35]  G. Shah,et al.  New directions in head and neck imaging , 2008, Journal of surgical oncology.

[36]  A. King,et al.  The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis. , 2008, The British journal of radiology.

[37]  J. Willatt,et al.  MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. , 2008, Radiology.

[38]  E. Hauth,et al.  Breast Cancer Staging in a Single Session: Whole-Body PET/CT Mammography , 2008, Journal of Nuclear Medicine.

[39]  E. Babin,et al.  PET/CT for assessing mandibular invasion by intraoral squamous cell carcinomas , 2008, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

[40]  Bernd J Pichler,et al.  Multimodal imaging approaches: PET/CT and PET/MRI. , 2008, Handbook of experimental pharmacology.